BATS BZX Real-Time Price
As of 11:23am ET
| +0.05 / +0.17%|
The 8 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 37.00, with a high estimate of 40.00 and a low estimate of 34.00. The median estimate represents a +24.24% increase from the last price of 29.78.
The current consensus among 8 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.